MEI Pharma MEI Pharma To Present at Two Upcoming Investor Conferences Wed, 14 Mar 2018 05:00:00 -0700 MEI Pharma Appoints Industry Veteran Frederick W. Driscoll to its Board of Directors Mon, 26 Feb 2018 05:00:00 -0800 MEI Pharma Interim Data Review Supports Continuation of Clinical Study Evaluating ME-344 in Patients with Breast Cancer Interim data further support potential of ME-344 to reverse resistance to antiangiogenic therapy Tue, 13 Feb 2018 05:00:00 -0800 MEI Pharma Reports Second Quarter Fiscal Year 2018 Results Pipeline advancement continues, including clearance of voruciclib IND by FDA and pracinostat Orphan Drug Designation by EMA Thu, 08 Feb 2018 05:00:00 -0800 Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug Designation from the European Medicines Agency for the Treatment of Acute Myeloid Leukemia (AML) Thu, 11 Jan 2018 00:00:00 -0800